Fig. 2From: The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in KoreaKaplan-Meier survival estimates among patients with P. mirabilis bacteremia. ESBL, extended spectrum β-lactamBack to article page